| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,130,800 | 1,007,200 | 1,056,600 | 1,098,200 | | Cost of Revenue | 198,300 | 177,800 | 186,800 | 194,700 | | | Gross Profit | 932,500 | 829,400 | 869,800 | 903,500 | | | Operating Expenses | | Research Development | 161,600 | 182,100 | 215,000 | 186,600 | | Selling General and Administrative | 441,900 | 484,500 | 426,500 | 440,400 | | Non Recurring | 1,000 | 42,100 | 3,700 | (200) | | Others | 35,500 | 38,600 | 40,900 | 39,300 | | | | Total Operating Expenses | 640,000 | 747,300 | 686,100 | 666,100 | | | | Operating Income or Loss | 292,500 | 82,100 | 183,700 | 237,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (17,000) | 700 | 28,400 | 16,400 | | Earnings Before Interest And Taxes | 275,500 | 82,800 | 212,100 | 253,800 | | Interest Expense | 18,500 | 19,400 | 15,900 | 14,500 | | Income Before Tax | 257,000 | 63,400 | 196,200 | 239,300 | | Income Tax Expense | 80,200 | 18,400 | 45,200 | 69,400 | | Minority Interest | (1,000) |
-
| (400) | (600) | | | | Net Income From Continuing Ops | 175,800 | 45,000 | 150,600 | 169,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 175,800 | 45,000 | 150,600 | 169,300 | | Preferred Stock And Other Adjustments | 300 | (300) |
-
|
-
| | | Net Income Applicable To Common Shares | $176,100 | $44,700 | $150,600 | $169,300 |
|
2.03% Nasdaq 0.00%
Income Statement
